Keywords: alkermes, starts, ph, iii, trial, naltrexone, xr

Alkermes starts Ph III trial of naltrexone XR

Article | 15 April 2002

Alkermes of the USA has started a pivotal, 400-patient clinical trial ofVivitrex, an extended-release formulation of the opiate antagonist naltrexone, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

naltrexone

Revia

Nystatin

Go to drug listing